Esketamine outperforms one of the standard drugs for treatment-resistant major depression

A major clinical trial shows that the drug, esketamine, one of the two main forms of ketamine, outperforms one of the standard treatments for treatment-resistant major depression.

Related Keywords

Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Frankfurt ,Brandenburg ,Germany ,Andreas Reif ,Danielle Ellis ,Goethe University Frankfurt ,New England Journal ,Depression Rating ,Clinical Depression ,Depression ,Ketamine ,Antidepressant ,Antipsychotic ,Hronic ,Clinical Trial ,Depressive Disorder ,Hospital ,Major Depressive Disorder ,Medicine ,Nasal Spray ,Research ,Erotonin ,